| Designing antimicrobial peptides: form follows function CD Fjell, JA Hiss, REW Hancock, G Schneider Nature reviews Drug discovery 11 (1), 37-51, 2012 | 1904 | 2012 |
| Deep learning in drug discovery E Gawehn, JA Hiss, G Schneider Molecular informatics 35 (1), 3-14, 2016 | 634 | 2016 |
| Identification of New PNEPs Indicates a Substantial Non-PEXEL Exportome and Underpins Common Features in Plasmodium falciparum Protein Export A Heiber, F Kruse, C Pick, C Grüring, S Flemming, A Oberli, H Schoeler, ... PLoS pathogens 9 (8), e1003546, 2013 | 179 | 2013 |
| Recurrent neural network model for constructive peptide design AT Muller, JA Hiss, G Schneider Journal of chemical information and modeling 58 (2), 472-479, 2018 | 168 | 2018 |
| An Unusual ERAD-Like Complex Is Targeted to the Apicoplast of Plasmodium falciparum S Spork, JA Hiss, K Mandel, M Sommer, TWA Kooij, T Chu, G Schneider, ... Eukaryotic cell 8 (8), 1134-1145, 2009 | 154 | 2009 |
| modlAMP: Python for antimicrobial peptides AT Müller, G Gabernet, JA Hiss, G Schneider Bioinformatics 33 (17), 2753-2755, 2017 | 107 | 2017 |
| Membranolytic anticancer peptides G Gabernet, AT Müller, JA Hiss, G Schneider MedChemComm 7 (12), 2232-2245, 2016 | 77 | 2016 |
| Proteomic and genetic analyses demonstrate that Plasmodium berghei blood stages export a large and diverse repertoire of proteins EM Pasini, JA Braks, J Fonager, O Klop, E Aime, R Spaccapelo, TD Otto, ... Molecular & Cellular Proteomics 12 (2), 426-448, 2013 | 77 | 2013 |
| Designing anticancer peptides by constructive machine learning F Grisoni, CS Neuhaus, G Gabernet, AT Müller, JA Hiss, G Schneider ChemMedChem 13 (13), 1300-1302, 2018 | 73 | 2018 |
| Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA TP Schmidt, AM Perna, T Fugmann, M Böhm, J Hiss, S Haller, C Götz, ... Scientific reports 6 (1), 23264, 2016 | 73 | 2016 |
| Advancing drug discovery via GPU-based deep learning E Gawehn, JA Hiss, JB Brown, G Schneider Expert opinion on drug discovery 13 (7), 579-582, 2018 | 63 | 2018 |
| Scaffold hopping from natural products to synthetic mimetics by holistic molecular similarity F Grisoni, D Merk, V Consonni, JA Hiss, SG Tagliabue, R Todeschini, ... Communications Chemistry 1 (1), 44, 2018 | 59 | 2018 |
| Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis A Button, D Merk, JA Hiss, G Schneider Nature machine intelligence 1 (7), 307-315, 2019 | 58 | 2019 |
| Adhesion, Invasion, and Agglutination Mediated by Two Trimeric Autotransporters in the Human Uropathogen Proteus mirabilis P Alamuri, M Löwer, JA Hiss, SD Himpsl, G Schneider, HLT Mobley Infection and immunity 78 (11), 4882-4894, 2010 | 55 | 2010 |
| Architecture, function and prediction of long signal peptides JA Hiss, G Schneider Briefings in bioinformatics 10 (5), 569-578, 2009 | 52 | 2009 |
| Hybrid network model for “deep learning” of chemical data: application to antimicrobial peptides P Schneider, AT Müller, G Gabernet, AL Button, G Posselt, S Wessler, ... Molecular informatics 36 (1-2), 1600011, 2017 | 50 | 2017 |
| In silico design and optimization of selective membranolytic anticancer peptides G Gabernet, D Gautschi, AT Müller, CS Neuhaus, L Armbrecht, PS Dittrich, ... Scientific reports 9 (1), 11282, 2019 | 44 | 2019 |
| Immunosuppressive Small Molecule Discovered by Structure‐Based Virtual Screening for Inhibitors of Protein–Protein Interactions T Geppert, S Bauer, JA Hiss, E Conrad, M Reutlinger, P Schneider, ... Angewandte Chemie International Edition 51 (1), 258-261, 2012 | 44 | 2012 |
| Neighborhood‐Preserving Visualization of Adaptive Structure–Activity Landscapes: Application to Drug Discovery M Reutlinger, W Guba, RE Martin, AI Alanine, T Hoffmann, A Klenner, ... Angewandte Chemie International Edition 50 (49), 11633-11636, 2011 | 44 | 2011 |
| Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors G Schneider, T Geppert, M Hartenfeller, F Reisen, A Klenner, ... Future medicinal chemistry 3 (4), 415-424, 2011 | 43 | 2011 |
Michael ReutlingerF. Hoffmann-La Roche AGVerified email at roche.com
